Price $38.93 |
Market Cap
202.1B
|
Sector Health Care |
Div. Growth
5.60%
|
|
P/E
29.1
|
P/B
3.1
|
P/S
4.68
|
Dividend %
4.30%
|
|
P/CF
416.5
|
P/FCF
53.3
|
Op. Cash Flow
14.4M
|
FCF
0.6
|
|
Op. Margin
17.90%
|
Net Margin
22.90%
|
ROE
14.90%
|
ROI
7.60%
|
|
ROA
5.70%
|
EPS Growth
-40.70%
|
Current Ratio
1.4
|
Debt/Equity
58.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AEterna Zentaris Inc. (USA) (AEZS) | $0.91 | - | - | 133.3M | Strong Buy |
| RadNet Inc. (RDNT) | $22.24 | - | - | 1.14B | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $23.93 | - | - | 888.4M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $65.60 | - | 3.10% | 141.03B | Strong Buy |
| Regulus Therapeutics Inc (RGLS) | $1.23 | - | - | 113.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
